Medinotec Inc. (MDNC) stock
Close on Oct 16, 2026Market cap $58.78MP/E –Yield –
Medinotec Inc. saw revenue fall 10.9% to $10.21M over the twelve months to Aug 31, 2026. Operating income fell 79.6% to $672.09K, moving the operating margin from 28.7% to 6.6%. Free cash flow was $905.44K, up 14.8% from a year earlier. At the latest close the market valued the company at $58.78M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Aug 31, 2026
Valuation
- Market cap
- $58.78M
- P/E ratio
- –
- Price to sales
- 5.76
- Price to book
- 9.91
- Dividend yield
- –
- Free cash flow yield
- 1.54%
Fundamentals
- Revenue
- $10.21M
- Net income
- $597.03K
- Free cash flow
- $905.44K
- Book value per share
- $0.50
- Diluted shares
- 12M
Trading
- Previous close
- $5.00
- Open
- $5.00
- Day's range
- $5.00 – $5.00
- Volume
- 0
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 16, 2026. The S&P 500 is measured by the SPY fund.
| Period | MDNC | S&P 500 | Difference | MDNC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +1.5% | −1.5 pts | ||
| 3 months | 0.0% | +1.9% | −1.9 pts | ||
| Year to date | 0.0% | +12.8% | −12.8 pts | ||
| 1 year | 0.0% | +16.8% | −16.8 pts | ||
| 3 years | 0.0% | +81.5% | −81.5 pts | 0.0% | +22.0% |
Five years at a glance
Fiscal years 2022 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
Free cash flow
Press releases
Releases Medinotec filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- News
- Update
- Update
- Update
About Medinotec
Surgical & Medical Instruments & Apparatus
Medinotec, Inc. is a medical device company that develops, manufactures, and distributes specialized interventional healthcare products. The company operates across two principal areas: proprietary medical devices and the distribution of third-party medical products under exclusive or non-exclusive agreements. Its proprietary offerings focus on interventional cardiology and interventional endolaryngeal endoscopy, featuring products such as the Trachealator non-occlusive airway dilation balloon, the Outflo aortic valve dilation balloon catheter, and the Cape Cross line of percutaneous transluminal coronary angioplasty balloon catheters. It also distributes cardiology and renal dialysis technologies. The company's customer base consists primarily of hospitals, healthcare providers, and specialized medical centers of excellence.
Company profile, executives and historyMedinotec stock: common questions
What is Medinotec's stock price?
MDNC closed at $5.00 on Oct 16, 2026, up 0.00% on the day.
What is Medinotec's market cap?
Medinotec was worth $58.78M at the close on Oct 16, 2026: the share price times the diluted shares outstanding.
How much revenue does Medinotec make?
Medinotec reported revenue of $10.21M for the twelve months to Aug 31, 2026, down 10.9% from a year earlier.
Does Medinotec pay a dividend?
No. Medinotec has not paid a cash dividend over the last twelve months.
How has MDNC stock performed over the past year?
Including dividends, MDNC returned 0.0% over the past year, against +16.8% for the S&P 500.
Who are Medinotec's competitors?
Companies most similar to Medinotec by business, industry and size include NSPR, BDMD, XAIR, WOK, ECIA.
See a number that looks wrong?